Here are some of the top stories affecting key drug and biotech stocks that have links through to more in-depth coverage and analysis today at the website BioHealthInvestor.com: Rigel Pharmaceuticals Inc.’s (NASDAQ: RIGL) Phase IIb trial results Thursday morning of its rheumatoid arthritis candidate R788, is boosting its stock on speculation it may help the company [[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Posts Tagged the-website
Warren Buffett of Berkshire Hathaway Inc. (NYSE: BRK.A) (NYSE: BRK.B) is essentially supporting a second stimulus package.
When we first floated the notion that Direxion may need to consider conducting a reverse stock split on its two Triple-Leverage cult ETFs for the financial sector, this was a notion that was not that popular despite the company’s hint that a reverse split was likely before the market temporarily interrupted that need. Now this [[ This is a content summary only. Visit my website for full links, other content, and more! ]]
